Abiopharma

News list

PEACOCK DAVID A 🟢 acquired 80.0K shares (1 derivative) of Advantage Solutions Inc. (ADV) Transaction Date: Apr 29, 2026 | Filing ID: 201633

Full text

News bot May 1, 2026, 8:45 p.m.
🔍 PEACOCK DAVID A (Executive)

Company: Advantage Solutions Inc. (ADV)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 80,000
Detailed Transactions and Holdings:
- Acquired 56,000 shares of Class A Common Stock (Direct)
  Date: 2026-04-29 | Code: A | equity_swap_involved: false | shares_owned_after: 4,045,102.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 24,000 shares of Performance Restricted Stock Unit (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: false | shares_owned_after: 24,000.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
Footnotes:
- F1: Represents an award of restricted stock units (RSUs) that is a contingent right to receive Class A Common Stock upon vesting. The RSUs are scheduled to vest in equal installments on each of the first, second and third anniversaries of the grant date.
- F2: Represents an award of performance restricted stock units (PSUs) that is a contingent right to receive Class A Common Stock upon vesting. Subject to the achievement of certain performance conditions based on Advantage Cash Earnings and Adjusted EBITDA Margin, the PSUs are scheduled to vest on the third anniversary of the grant date and may vest from 0% to 200% of the target number of PSUs reported on this Form 4.